Extracellular p53 fragment re-enters K-Ras mutated cells through the caveolin-1 dependent early endosomal system

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• K-Ras mutations drive over 30% of human cancers, particularly pancreatic cancer.
• Oncogenic K-Ras promotes the secretion of p53, a tumor suppressor protein, in complex with Snail.
• Understanding the fate of extracellular p53 is crucial for developing targeted cancer therapies.

Purpose of the Study:

• To investigate the re-uptake mechanism of extracellular p53 by cancer cells.
• To identify the specific regions of p53 involved in its interaction with K-Ras mutated cells.
• To explore the potential of p53 as a delivery vehicle and diagnostic marker for K-Ras driven malignancies.

Main Methods:

• Tracking extracellular p53's destination after secretion from K-Ras mutated cells.
• Utilizing serial deletion analysis to map p53 domains responsible for caveolin-1 binding and endocytosis.
• In vivo studies using tumor models formed by K-Ras and H-Ras mutated cells to assess p53 uptake.

Main Results:

• Extracellular p53 is specifically re-endocytosed by cancer cells harboring oncogenic K-Ras.
• The p53 DNA-binding domain (93-143 AA) mediates caveolin-1 association and caveolin-1-dependent endocytosis.
• In vivo studies confirmed uptake of recombinant p53 by K-Ras mutated tumors, but not H-Ras mutated tumors.

Conclusions:

• Extracellular p53 is selectively internalized by K-Ras mutated cells through a caveolin-1 dependent pathway.
• A specific p53 fragment (93-143 AA) is key for this targeted cellular uptake.
• This p53 fragment holds promise as a specific delivery tool and diagnostic marker for K-Ras mutated cancers.